Biolife Solutions (BLFS) Operating Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Operating Expenses data on file, last reported at $17.5 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 14.18% year-over-year to $17.5 million in Q1 2026; TTM through Mar 2026 was $71.0 million, a 47.54% increase from a year earlier, with the FY2025 full-year figure at $78.7 million, up 44.25% from the prior year.
• Operating Expenses for Q1 2026 stood at $17.5 million, up from -$16.7 million in the prior quarter.
• Over the last five years, Operating Expenses for BLFS reached as high as $117.1 million in Q2 2022 and fell as low as -$131.6 million in Q4 2022.
• Historically, Operating Expenses has averaged $17.4 million across 5 years, with a median of $21.8 million in 2024.
• On a YoY basis, Operating Expenses climbed as much as 227.46% in 2022 and fell as far as 335.98% in 2022.
• Year by year, Operating Expenses stood at -$131.6 million in 2022, then soared by 55.77% to -$58.2 million in 2023, then soared by 82.84% to -$10.0 million in 2024, then tumbled by 66.83% to -$16.7 million in 2025, then jumped by 204.87% to $17.5 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $17.5 million in Q1 2026, -$16.7 million in Q4 2025, and $28.2 million in Q3 2025.